Important information regarding cookies and
By using this website, you consent to the use of cookies in accordance with the IMB Cookie Policy. For more information on cookies, see our Cookie Policy.
Full Version | Search

The Irish Medicines Board -

IMB Logo

Drug Safety Newsletter 46th Edition

03 May 2012

Topics covered in this edition of the newsletter include:

  • Proton-pump inhibitors - Association with hypomagnesaemia with long term use
  • Metoclopramide - New recommendations for treatment of children
  • Gonadotrophin-releasing hormone agonists - Risk of depression
  • HMG-CoA reductase inhibitors - Risk of new onset diabetes in patients already at increased risk of developing diabetes
  • Varenicline (Champix) and cardiovascular safety
  • Adverse drug reaction reporting experience during 2010
  • Adverse reaction and quality defect reporting including herbal medicines

Drug Safety Newsletter 46th Edition

Date Printed: 18 April 2014

© Irish Medicines Board 2014 | Developed by Engine Solutions

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971